Navigation Links
Synvista Therapeutics Presents New Preclinical Data Demonstrating the Value of Haptoglobin Genotype Testing In Diabetes at ACC Scientific Sessions
Date:3/31/2008

Hb by Hp in diabetic mice that were also tested for Hp type. The study showed that in these mice, the combination of diabetes and the Hp2-2 genotype was associated with a two-to-three-fold increase in the half-life of the Hp-Hb complex compared to other Hp types. Further, a greater than 10-fold increase was found in the association of Hp-2-Hb and HDL in these mice. The study also demonstrated that vitamin E supplementation prevented the impairment of reverse cholesterol transport in diabetic mice with the Hp2-2 genotype.

About Haptoglobin 2-2

The Hp protein is polymorphic in humans, occurring with two alleles, 1 and 2, existing at the Hp genetic locus. Three phenotypes linked to the three genotypes, Hp 1-1, Hp 1-2 and Hp 2-2, can be identified using an ELISA assay. In multiple independent prospective longitudinal studies of more than 20,000 individuals, it has been established that the Haptoglobin genotype is an independent risk factor for cardiovascular disease, with a specific relationship to patients with diabetes mellitus. After accounting for conventional cardiovascular risk factors and diabetes characteristics in these studies, research has demonstrated that there is a 2-5 fold increased risk of cardiovascular disease in people with both diabetes and the Hp 2-2 genotype (approximately 40 percent of all diabetes patients).

About Synvista Therapeutics

Synvista Therapeutics is a biopharmaceutical company developing drugs to treat and prevent cardiovascular disease and nephropathy in people with diabetes. The Company believes it has identified several product candidates that represent novel approaches to some of the largest pharmaceutical markets. The Company's portfolio includes orally bioavailable, organoselenium mimics of glutathione peroxidase. These compounds metabolize lipid peroxides and have the potential to limit myocardial damage subsequent to a myocardial infarction. The Company is developing a clinical diagnostic test, base
'/>"/>

SOURCE Synvista Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Synvista Therapeutics Announces Initiation of Phase 2 Study With Alagebrium for Chronic Heart Failure
2. Synvista Announces New Data Showing Haptoglobin Type Predicts Effectiveness of Tight Glycemic Control on Cardiovascular Outcomes in Patients with Diabetes
3. Synvista Collaboration Demonstrates in Preclinical Studies the Mechanism for Defective Cholesterol Transport in Patients with Diabetes
4. Synvista Therapeutics Highlights New Data Demonstrating the Clinical Benefit of Vitamin E Therapy in Patients Identified on the Basis of Haptoglobin Phenotype Testing
5. Synvista Therapeutics Alagebrium Shows Potential for use in Treating Diabetes-Related Gastrointestinal Complications
6. Cell Therapeutics, Inc. (CTI) Announces Enrollment Complete in Phase III EXTEND (PIX301) Clinical Trial of Pixantrone in Patients With Second or Greater Relapse of Diffuse Large B Cell NHL
7. Dynamis Therapeutics, Inc. Discovers RAGE Inhibitor
8. Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
9. Amicus Therapeutics Presents Data from Clinical Ex Vivo Response Study and Phase 1 Studies of AT2220
10. Ception Therapeutics Initiates Phase II/III Clinical Trial for Its Lead Product Reslizumab in Eosinophilic Esophagitis (EE) in Children
11. Cell Therapeutics, Inc. (CTI) Submits European Marketing Authorization Application for XYOTAX(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... 2015  Hill-Rom Holdings, Inc., (NYSE: HRC ) ... the Morgan Stanley Global Healthcare Conference on September 16, ... invited to listen to the live discussion via the ... at https://cc.talkpoint.com/morg007/091615a_ae/?entity=49_UCJPU8N . A recorded replay ... the conclusion of the live event and accessible via ...
(Date:8/27/2015)... Mass. and TORONTO , ... ) (OTCQB: GNBT) today announced the issuance of a ... Company,s proprietary buccal insulin spray product.  The white paper ... of the Company,s stockholders by Dr. James H. ... The white paper may be viewed online on the ...
(Date:8/27/2015)... Major pharmaceutical and medical device companies and leading law firms ... Philadelphia on Oct. 20, discussing issues surrounding regulatory ... HB Litigation Conferences has announced. To learn ... The program is co-chaired by Megan ... Michelle Hart Yeary of Dechert LLP. Topics ...
Breaking Medicine Technology:Generex Announces Issuance of Buccal Insulin White Paper 2Generex Announces Issuance of Buccal Insulin White Paper 3Generex Announces Issuance of Buccal Insulin White Paper 4Pharmaceutical, Medical Device Law Seminar Features In-House, Outside Counsel 2Pharmaceutical, Medical Device Law Seminar Features In-House, Outside Counsel 3
... 2012 ClearCanvas Inc., an innovative medical imaging ... with DPR of San Ramon, California, a technology ... the radiology industry. The companies will work together ... distribute their combined solutions. DPR develops ...
... May 30, 2012 Glooko , Inc., makers ... Care, makers of ACCU-CHEK blood glucose monitoring ... their co-promotion of the Glooko Logbook solution in the ... ACCU-CHEK customers who prefer to manage their diabetes on ...
Cached Medicine Technology:ClearCanvas Partners With DPR to Offer CaseReader™, an Integrated Technology Structured Reporting Solution for Medical Imaging Professionals 2ClearCanvas Partners With DPR to Offer CaseReader™, an Integrated Technology Structured Reporting Solution for Medical Imaging Professionals 3ClearCanvas Partners With DPR to Offer CaseReader™, an Integrated Technology Structured Reporting Solution for Medical Imaging Professionals 4Glooko Launches the Glooko™ IR Adapter to Give ACCU-CHEK® Blood Glucose Meter Customers Access to the Glooko Logbook Solution 2Glooko Launches the Glooko™ IR Adapter to Give ACCU-CHEK® Blood Glucose Meter Customers Access to the Glooko Logbook Solution 3Glooko Launches the Glooko™ IR Adapter to Give ACCU-CHEK® Blood Glucose Meter Customers Access to the Glooko Logbook Solution 4Glooko Launches the Glooko™ IR Adapter to Give ACCU-CHEK® Blood Glucose Meter Customers Access to the Glooko Logbook Solution 5
(Date:8/28/2015)... ... August 28, 2015 , ... Dr. Gregory K. Toumayan, D.C., Q.M.E., is ... in shoulder pain, hip pain, neck pain, stiffness, muscle spasms, and numbness. ... University of Illinois, and then went on to earn his title of Doctor of ...
(Date:8/28/2015)... Newton, Mass. (PRWEB) , ... August 28, 2015 ... ... is proud to announce its collaboration with coffee connoisseur and Emmy-nominated actress, Sofia ... Bar™ brewer. It features revolutionary Thermal Flavor Extraction™ technology, which delivers a variety ...
(Date:8/28/2015)... ... August 28, 2015 , ... United Benefit Advisors (UBA), the ... Group as its newest Partner Firm. Founded in 1924 and headquartered in Pittsburgh, ... on their goals. Within the past 10 years, TJS Insurance Group has emerged ...
(Date:8/28/2015)... ... August 28, 2015 , ... A complimentary webinar offered by healthcare consulting ... Services’ (CMS) proposal to mandate bundled payments through the Comprehensive Care for ... Game Day: Comprehensive Care for Joint Replacement,” takes place at 12 noon EDT on ...
(Date:8/28/2015)... ... , ... Santa Rosa was recently recognized, for the fourth consecutive year, as ... KLAS “2015 Midterm Performance Review: Software & Services”, Santa Rosa achieved the highest rating ... and KLAS are directly related to our company culture.” said Richard Helppie, chairman and ...
Breaking Medicine News(10 mins):Health News:Healthpointe Welcomes Dr. Gregory K. Toumayan, Chiropractor, to Colton, Temecula, and Perris 2Health News:Healthpointe Welcomes Dr. Gregory K. Toumayan, Chiropractor, to Colton, Temecula, and Perris 3Health News:Sofia Vergara Partners With SharkNinja® To Launch The Ninja Coffee Bar™ 2Health News:Sofia Vergara Partners With SharkNinja® To Launch The Ninja Coffee Bar™ 3Health News:TJS Insurance Group Is Latest Partner Firm To Join United Benefit Advisors 2Health News:TJS Insurance Group Is Latest Partner Firm To Join United Benefit Advisors 3Health News:PYA Offers Complimentary CCJR Webina — Game On 2Health News:PYA Offers Complimentary CCJR Webina — Game On 3Health News:Santa Rosa Consulting Recognized by Modern Healthcare as One of the Top 100 Best Places to Work and from KLAS Research with the Highest Rating for Go-Live Support 2
... (April 26, 2010, 4 p.m. EDT) Myelodysplastic syndromes (MDS) ... five times more common in seniors than previously thought, according ... Cancer Center at Hackensack University Medical Center. The study ... at much higher risk for heart attack, diabetes and other ...
... development of screening tests for early detection , MONDAY, April ... of ovarian cancer may lead to the development of a ... In the study, scientists uncovered early tumors and precancerous lesions ... surface. , "This is the first study giving very strong ...
... ... , ... -- Few of us, by the age of 25, have a life story complete and ... born author, Nathalia Zongo, who lived a childhood of crisis, hardship and deliverance in a ...
... believe , MONDAY, April 26 (HealthDay News) -- Two kinds ... the risk of heart disease and high blood pressure by ... , In a new study, researchers report that the findings ... when it comes to protecting the body from high blood ...
... study finds , MONDAY, April 26 (HealthDay News) -- ... new study finds that people battling depression reach for ... , Many people believe that "when they are feeling ... said lead researcher Dr. Beatrice A. Golomb, an associate ...
... or diabetes now widespread, CDC survey finds , MONDAY, ... American adults have either high blood pressure, high cholesterol ... disease, stroke and other cardiovascular problems, a new government ... National Health and Nutrition Examination Survey (NHANES) 1999-2006 shows ...
Cached Medicine News:Health News:MDS, a blood cancer, strikes nearly 5 times more Americans than previously thought 2Health News:MDS, a blood cancer, strikes nearly 5 times more Americans than previously thought 3Health News:Study Makes Strides in Understanding Ovarian Cancer 2Health News:Autobiography Gives Child's Eye View of West African Regime Change and Family Fallout 2Health News:Autobiography Gives Child's Eye View of West African Regime Change and Family Fallout 3Health News:Autobiography Gives Child's Eye View of West African Regime Change and Family Fallout 4Health News:Chocolate a Sweet Pick-Me-Up for the Depressed 2Health News:Chocolate a Sweet Pick-Me-Up for the Depressed 3Health News:Nearly Half of U.S. Adults Have Heart Risk Factors 2Health News:Nearly Half of U.S. Adults Have Heart Risk Factors 3
Two prong stainless steel tips; with titanium handle/...
Straight shaft with fine pointed 0.3mm Tips for Grasping Delicate Capsule; In Titanium....
12mm from bend to 0.12mm 1x2 teeth; In Titanium....
Straight Shafts with 0.12mm 1X2 Teeth With 5mm Tying Platform; In Titanium...
Medicine Products: